News
11h
GlobalData on MSNFDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’sThe US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...
The test can aid doctors in determining whether a patient's memory problems are due to Alzheimer's or a number of other ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the ...
Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results